According to the NHS, people infected with RSV will typically show symptoms within the first few days of infection. This can ...

Respiratory syncytial virus, commonly known as RSV, is often associated with cold-like symptoms in young children.

Over the course of a two-day meeting, vaccine advisers to the US Food and Drug Administration voted in favor of approval for RSV vaccines for adults over the age of 60. The vaccine candidates, made by ...

In a new study, adults 45 and up who got this seasonal virus had a higher risk of major heart issues, especially in the first ...

Recovering from respiratory syncytial virus often doesn't end when it's time to leave the hospital, even for younger adults.

Respiratory syncytial virus (RSV) cases are on the rise across the UK, with UKHSA data showing positivity rates reaching 10% ...

Respiratory Syncytial Virus or RSV is one of the most common respiratory viruses circulating today. Often thought of as only being dangerous to babies and toddlers due to how often child-related RSV ...

RSV hospitalization rates in older adults reached 58.3 per 100,000 in winter 2023-24, nearly half the rate of influenza at 114.6 per 100,000. Mortality and clinical outcomes were comparable between ...

A new study has found that a significant percentage of adults in the United States have at least one risk factor for severe respiratory syncytial virus (RSV), even as eligibility for the RSV ...

Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA) on Monday released topline data from RSVHR Phase 2b study of zelicapavir in outpatient adults with acute respiratory syncytial virus (RSV) infection who are ...

Learn what happens to cells inside the nose during an RSV infection, and why infants are so vulnerable to the virus.